G

GMED

Globus Med Inc

57.31

0.71+1.25%
After Hours: 56.84  -0.47  -0.82%19:26 07/09 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE56.77/56.60
TODAY RANGE55.51-57.35
VOL2.16M
MARKET CAP7.76B
52 WEEK RANGE54.48-94.93
AVG VOL (3M)1.51M
% TURNOVER1.59%
TURNOVER--
P/E (TTM)42.86
% RANGE3.25%
EPS(TTM)1.337
P/E(FORWARD)22.30
P/B1.898
BVPS30.20
DIVIDEND--
P/S3.126
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.43B
SHARES OUTSTANDING135.38M
NEXT EARNINGS08/04-08/08
FREE FLOAT112.17M
LOT SIZE1
EX-DATE--
Same Industry
Name/Symbol
Change%
Price

G

Globus Med Inc

GMED

+1.25%
57.31

A

Atrion Corp

ATRI

0.00%
459.92

I

IDEXX Laboratories

IDXX

+0.34%
540.64

C

Cencora Inc.

COR

+0.71%
300.16

T

Teleflex Inc

TFX

-0.63%
118.93

S

Stryker Corp

SYK

+0.65%
392.05

W

West Pharm Svcs

WST

+2.59%
226.18

U

Ufp Technologies

UFPT

+1.83%
247.56

S

Shockwave Medical, Inc.

SWAV

0.00%
334.75

C

Cooper

COO

+0.93%
74.95

B

Becton Dickinson And Co

BDXB

--
48.16

B

Becton Dickinson & Co

BDX

+0.50%
175.50

U

Utah Med Prods

UTMD

-0.57%
57.26

A

Align Technology Inc

ALGN

+2.56%
200.48

H

Henry Schein

HSIC

+0.28%
74.16

G

Ge Healthcare Technologies Inc

GEHC

+0.41%
75.51

R

Repligen

RGEN

+0.98%
129.82

A

Abbott Labs

ABT

-0.11%
133.22

C

Conmed Corp

CNMD

+0.88%
52.91

M

Medtronic

MDT

+0.47%
89.00

Z

Zimmer Biomet

ZBH

+1.85%
95.20
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.